Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: BIOINTRON BIOLOGICAL USA INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-07-12 to 2025-07-11
Current total value of award: $49946.1
Description: ANTIBODY EXPRESSION SERVICE